Specifically, the association between GLP-1 RA therapy and attenuated aortic dilatation remained significant across multiple definitions of progression (≥0.5 mm and ≥1.0 mm increase), supporting the consistency of the findings. The gene discussed is GLP1R; the disease is Vascular dilatation.